Back to search
FDAFDA · Food and drugs·Recall number D-0494-2019

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.

Published February 20, 2019 · Recall initiated: January 15, 2019

Summary

FDA records drug Class II recall D-0494-2019, published February 20, 2019 and initiated January 15, 2019. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 35,328 bottles; Lot: Lot#: 00717005A, Exp 02/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tris Pharma Inc.
Distributor
One distributor who further distributed Nationwide in the USA.
Lot
Lot#: 00717005A, Exp 02/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24. recalled?

Yes. FDA published recall D-0494-2019 on February 20, 2019. Reported hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

What should I do if I have this product?

Voluntary: Firm initiated · Letter